Predictive Genetic Testing & Consumer/Wellness Genomics Market Trends and Overview

The market size for Predictive Genetic Testing & Consumer/Wellness Genomics was valued at USD 5.73 billion in 2022. It is projected to reach USD 16.35 billion by 2030, with a compound annual growth rate (CAGR) of 14% during the forecast period from 2023 to 2030.

This industry has witnessed significant growth and is expected to continue its upward trajectory in the coming years. The increasing demand for personalized healthcare and the advancements in genetic testing technologies are driving the market's expansion.

Predictive genetic testing and consumer/wellness genomics have gained prominence due to their potential to provide valuable insights into an individual's genetic makeup. These tests can help identify genetic predispositions to certain diseases, allowing for early intervention and personalized treatment plans.

Furthermore, the growing awareness among individuals about the importance of proactive health management has fueled the adoption of genetic testing services. Consumers are increasingly seeking information about their genetic profiles to make informed decisions regarding their health and well-being.

The market's growth is also attributed to the rising prevalence of chronic diseases and the need for effective disease management strategies. Genetic testing can aid in identifying individuals at a higher risk of developing certain conditions, enabling healthcare providers to implement preventive measures and tailor treatment approaches accordingly.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2445

Moreover, technological advancements in genomics and the decreasing costs of genetic testing have made these services more accessible to a wider population. This accessibility, coupled with the increasing availability of direct-to-consumer genetic testing kits, has contributed to the market's expansion.

In conclusion, the Predictive Genetic Testing & Consumer/Wellness Genomics market is poised for substantial growth in the coming years. The market's value is expected to reach USD 16.35 billion by 2030, driven by factors such as the demand for personalized healthcare, advancements in genetic testing technologies, and the growing awareness among individuals about proactive health management.

KEY MARKET SEGMENTATION:

By Test Type

• Predictive Testing
• Consumer Genomics
• Wellness Genomics

By Application

• Breast & Ovarian Cancer
• Cardiovascular Screening
• Diabetic Screening & Monitoring
• Colon Cancer
• Parkinsonism/Alzheimer’s Disease
• Urologic Screening/Prostate Cancer Screening
• Orthopedic & Musculoskeletal

By Setting Type

• Proteomic Testing
• Metabolic Testing
• Genomic Testing

KEY PLAYERS:

Some of the major key players are Abbott Laboratories, Bio-Rad Laboratories Inc., Counsyl, Inc., Agilent Technologies, Bureau Gravimétrique International, Genesis Genetics, ARUP Laboratories, Hoffmann-La Roche Ltd., Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific, Inc. and Other Players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com